0
0
0
0
1
2
3
$0
Is Procter & Gamble solid or fragile? The Finex Financial Health Scanner reads PG's real financial statements and scores its debt, liquidity, margins, cash flow and growth, with the Altman Z-score, the Piotroski F-score and the red flags explained in plain words.
| Revenue (FY2026) | $87.0B |
|---|---|
| Net income | $16.0B |
| Operating margin | 22.7% |
| Net margin | 18.4% |
| Cash and investments | $9.9B |
| Total debt | $34.1B |
| Free cash flow | $12.7B |
| Revenue growth (1 year) | 3.3% |
Data: Nasdaq and Yahoo Finance. Educational, not financial advice.